Completed Access to Information Requests

Follow:

  • RSS
  • Cite

    Cite

    APA

    Open Government - Government of Canada. (2017, December 10). Completed Access to Information Requests. Retrieved from http://open.canada.ca/en/search/ati?search_api_fulltext=&sort_by=year&page=3193
    MLA

    “Completed Access to Information Requests.” Open Government - Government of Canada, 10 December 2017, http://open.canada.ca/en/search/ati?search_api_fulltext=&sort_by=year&page=3193
    (Report an issue with citation)
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 61777 record(s)

Req # A-2021-000422

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-101786-296.

Organization: Health Canada

5 page(s)
March 2022

Req # A-2021-000431

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100736-599.

Organization: Health Canada

11 page(s)
March 2022

Req # A-2021-000537

Adverse Drug Reaction (ADR) for ALIROCUMAB. Report number: E2B_03502076.

Organization: Health Canada

38 page(s)
March 2022

Req # A-2021-000565

Adverse Drug Reactions (ADRs). Report numbers: 000938598, 000940364, 000941460, 000942839, 000942951, 000948138, E2B_03780743.

Organization: Health Canada

59 page(s)
March 2022

Req # A-2021-000605

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-113740-115.

Organization: Health Canada

40 page(s)
March 2022

Req # A-2021-000623

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075019-732.

Organization: Health Canada

6 page(s)
March 2022

Req # A-2021-000653

Adverse Drug Reactions (ADRs) for FUROSEMIDE. Report numbers: E2B_03406733, E2B_03400650, E2B_03484838, E2B_03484971, E2B_03495322, E2B_03495322, 000919565, E2B_03347519, E2B_03478062, E2B_03429750, E2B_03476211, 000921601, E2B_03478098, 000918752, E2B_03516718, E2B_03508344, E2B_03478199, 000921593, 000928788, E2B_03443272, E2B_03480765.

Organization: Health Canada

401 page(s)
March 2022

Req # A-2021-000664

Adverse Drug Reaction (ADR) for INSULIN ASPART. Report number: E2B_03454918.

Organization: Health Canada

53 page(s)
March 2022

Req # A-2021-000760

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-101786-296.

Organization: Health Canada

5 page(s)
March 2022

Req # A-2021-000832

Adverse Drug Reaction (ADR) for PREDNISONE. Report number: E2B_03321797.

Organization: Health Canada

23 page(s)
March 2022
Date modified: